Oxygenta Pharmaceutical Ltd — Quarterly Results & Earnings

₹48.38

-3.44%

Profit Growth YoY-72.98%Latest quarter

Sales Growth YoY2.07%Latest quarter

Sales CAGR 5Y51.44%5 year compound

Profit CAGR 5Y0.75%5 year compound

📋

Quarterly Performance

YoY Profit Growth-72.98%

🔴 Significant decline

YoY Sales Growth+2.07%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

-7.25%

EPS Growth 5Y

11.65%

Interest Coverage

Higher = safer debt servicing

-4.63

ROE

N/A

ROCE

-24.93%

💡

Growth Analysis

Oxygenta Pharmaceutical Ltd reported YoY profit growth of -72.98% and revenue growth of 2.07% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 51.44% and profits at 0.75% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Oxygenta Pharmaceutical Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.